Mechanistically, ALA may support lipid metabolism through several pathways:60 Reduces oxidative stress in liver cells ALA works as an antioxidant by neutralizing reactive oxygen species (ROS) unstable molecules that can damage liver cells and interfere with fat metabolism
FDA approval and a manufacturers decision to market can move it later
Semaglutide and tirzepatide affect the areas in the brain that are responsible for dopamine-releasing behaviors and eliminate addictive urges, helping patients have increased control over their diet
Prognosis may be variable, depending on the degree of clinical involvement, particularly the degree and duration of metabolic acidosis and the effectiveness in preventing overwhelming sepsis
The most common adverse effects of semaglutide include nausea (occurring in up to 44% of patients on Wegovy's highest dose), vomiting, diarrhea, abdominal pain, and constipation